0001654954-20-006561.txt : 20200612 0001654954-20-006561.hdr.sgml : 20200612 20200612164617 ACCESSION NUMBER: 0001654954-20-006561 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200612 DATE AS OF CHANGE: 20200612 EFFECTIVENESS DATE: 20200612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GT Biopharma, Inc. CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-368883 FILM NUMBER: 20960762 BUSINESS ADDRESS: STREET 1: 310 N. WESTLAKE BLVD. STREET 2: SUITE 206 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 310 N. WESTLAKE BLVD. STREET 2: SUITE 206 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 FORMER COMPANY: FORMER CONFORMED NAME: OXIS INTERNATIONAL INC DATE OF NAME CHANGE: 19940916 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 D 1 primary_doc.xml X0708 D LIVE 0000109657 GT Biopharma, Inc. 9350 Wilshire Blvd Suite 203 Beverly Hills CA CALIFORNIA 90212 800-304-9888 DELAWARE OXIS INTERNATIONAL INC DDI PHARMACEUTICALS INC DIAGNOSTIC DATA INC /DE/ Corporation true Anthony Cataldo 9350 Wilshire Blvd Suite 203 Beverly Hills CA CALIFORNIA 90212 Director Executive Officer Steven Weldon 9350 Wilshire Blvd Suite 203 Beverly Hills CA CALIFORNIA 90212 Director Executive Officer Biotechnology Decline to Disclose 06b false 2020-04-20 false true true Debt convertible into equity false 0 Indefinite 2417000 Indefinite false 9 0 0 250000 true A portion of the proceeds of this offering will be used for general corporate purposes, including compensation to executive officers in their roles as employees. GT Biopharma, Inc. /s/ Steven Weldon Steven Weldon Chief Financial Officer 2020-06-11